BOM Capital Founded 1983
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 50
Average round size
info
The average size of a deal this fund participated in
$4M
Portfolio companies 39
Rounds per year 1.03
Lead investments 13
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.22
Exits 2
Stages of investment
Early Stage Venture
Private Equity
Seed
Areas of investment
Biotechnology
Energy
Enterprise
Health Care
Industrial
Summary

BOM Capital is the famous VC, which was founded in 1983. The leading representative office of defined VC is situated in the Tilburg. The fund was located in Europe if to be more exact in The Netherlands.

Opposing the other organizations, this BOM Capital works on 20 percentage points less the average amount of lead investments. The fund is constantly included in 2-6 deals per year. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top activity for fund was in 2015. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2015. The real fund results show that this VC is 5 percentage points more often commits exit comparing to other companies.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the BOM Capital, startups are often financed by Thuja Capital, EASME - EU Executive Agency for SMEs, Technology Development Fund. The meaningful sponsors for the fund in investment in the same round are Thuja Capital, TIIN Capital, BioGeneration Ventures. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs, BNP Paribas Private Equity, henQ.

The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Information Technology, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - The Netherlands. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight AcertaPharma, Protix Biosystems, ULU.

Besides them, we counted 1 critical employee of this fund in our database.

Read more
Notable deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
SendCloud
E-Commerce
Logistics
Shipping
Early Stage Venture
14M17 Nov 2020 Netherlands, Eindhoven
Salvia BioElectronics
Biotechnology
Medical Device
Therapeutics
Early Stage Venture
31M22 Sep 2020 Netherlands, Eindhoven
Citryll
Biopharma
Biotechnology
Medical
Medical Device
Neuroscience
Early Stage Venture
21M02 Jul 2020 Netherlands, " The Netherlands"}
Labelfuse
Analytics
Artificial Intelligence
Computer Vision
Drones
Health Diagnostics
Image Recognition
Machine Learning
Robotics
Software
Seed
234K08 Feb 2020 The Netherlands, Eindhoven
SendCloud
E-Commerce
Logistics
Shipping
Venture - Series Unknown
17 Oct 2019 Netherlands, Eindhoven
Lightyear
Automotive
Electric Vehicle
Energy
Finance
IT Infrastructure
Manufacturing
Software
Solar
Convertible Note
16M24 Jun 2019 United States, New York
Salvia BioElectronics
Biotechnology
Medical Device
Therapeutics
Seed
2M31 Jan 2019 Netherlands, Eindhoven
Ebookers Plc
Hotels and Resorts
Internet Retail
Leisure
Other Consumer Products and Services
Tourism
Travel
Travel Agency
Venture - Series Unknown
28 Sep 2018 United Kingdom, Westminster
Shypple
Logistics
Supply Chain Management
Seed
1M06 Sep 2018 The Netherlands, Rotterdam
News
Onera raises €10.5M in Series B funding
– Onera closed the Series B funding round, which brought the total funding raised to date above the €24M mark. – Innovation Industries led the round in collaboration with Invest-NL and with existing investors Jazz Pharmaceuticals, imec.xpand, BOM and 15th Rock. – The company intends to use the funds to execute clinical studies and further commercialize its sleep diagnostics and monitoring products in Europe and the United States. – Onera recently relocated its headquarters to the Brainport region in Eindho... Read more
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BOM Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: